Previous 10 | Next 10 |
Old West manages long only and long/short investment strategies based upon the companies that we uncover through our simple yet sound investment process. We outperformed the market by a wide margin, with our LP’s up on average 25% net of fees and our separate accounts up over 3...
Rafael Holdings Announces Inducement Grant Under NYSE Rule 303A.08 PR Newswire NEWARK, N.J. , April 16, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), today announced that on April 15, 2021 it made a grant to William Conkling of options to purch...
Rafael Pharmaceuticals (RFL) announces that it has crossed the enrollment of 150 patients in its Phase 3 clinical trial for patients with relapsed or refractory acute myeloid leukemia ((AML)).The multicenter, open-label, randomized pivotal trial is assessing the efficacy and safety of Ra...
CRANBURY, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that it has crossed the enrollment of 150 patients in its Phase...
Rafael Holdings (RFL): FQ2 GAAP EPS of -$0.50.Revenue of $1M (-19.4% Y/Y)Shares +5.4%.Press Release For further details see: Rafael Holdings reports FQ2 results
Rafael Holdings Reports Second Quarter Fiscal Year 2021 Results PR Newswire NEWARK, N.J. , March 17, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), reported revenue of $1.0 million and a loss per share of $0.50 for the second quarter of its...
Gainers: NLS Pharmaceutics NLSP +111%, Entera Bio ENTX +75%, Seelos Therapeutics SEEL +34%, Regulus Therapeutics (RGLS) +27%, Rafael (RFL) +27%.Losers: Marker Therapeutics MRKR -28%, Timber Pharmaceuticals (TMBR) -21%, Evoke Pharma EVOK...
Rafael Holdings Enhances Senior Management Team with Additions of Ameet Mallik, CEO and William Conkling, CCO Leadership Team Will Build on Pharma Investments PR Newswire NEWARK, N.J. , March 11, 2021 /PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), t...
Gainers: Sunesis Pharmaceuticals (SNSS) +38%, Owens & Minor (OMI) +32%, Salarius Pharmaceuticals (SLRX) +20%, Poseida Therapeutics (PSTX) +20%, PRA Health Sciences (PRAH) +19%.Losers: Rafael (RFL) -12%, Constellation Pharmaceuticals (CNST)...
Kahn Brothers’ 13F portfolio value increased from $528M to $579M this quarter. New York Community Bancorp, VOXX International, BlackBerry, and Patterson-UTI Energy were decreased during the quarter. The portfolio continues to be very concentrated with the top five positions...
News, Short Squeeze, Breakout and More Instantly...
Rafael Holdings Inc. Class B Company Name:
RFL Stock Symbol:
NYSE Market:
Rafael Holdings Inc. Class B Website:
NEWARK, N.J., April 04, 2023 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today announced that its Board of Directors has authorized the repurchase of up to $5 million of the Company's Class B common stock. “We remain committed to strategically and opportunistically deployi...
NEWARK, N.J., March 14, 2023 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its second quarter fiscal 2023 financial results for the three months and six months ended January 31, 2023. “Our strong balance sheet allows us to continue to fund our pipeline assets ...
NEWARK, N.J., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its first quarter fiscal 2023 financial results for the three months ended October 31, 2022. “We are pleased to have successfully completed the sale of our real estate asset located in N...